--- title: "Essentra Cancels 200,000 Shares in Ongoing Buyback Programme" type: "News" locale: "en" url: "https://longbridge.com/en/news/284512898.md" description: "Essentra has repurchased 200,000 shares as part of its ongoing buyback program, with plans to cancel these shares, reducing the total outstanding shares to 284,327,744. This move is part of Essentra's capital management strategy, potentially enhancing earnings per share and affecting shareholders' voting rights. The latest analyst rating for Essentra (GB:ESNT) is a Buy with a £130.00 price target, although some analysts view it as Neutral due to weak profitability and cash flow trends. The current market cap is £237.2M." datetime: "2026-04-29T07:19:49.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284512898.md) - [en](https://longbridge.com/en/news/284512898.md) - [zh-HK](https://longbridge.com/zh-HK/news/284512898.md) generator: "portal-rs" --- # Essentra Cancels 200,000 Shares in Ongoing Buyback Programme ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks An update from Essentra ( (GB:ESNT) ) is now available. Essentra has continued to execute its previously announced share buyback programme, repurchasing 200,000 ordinary shares of 25 pence each on the London Stock Exchange between 22 and 27 April 2026 at volume‑weighted average prices ranging from about 81.6p to 84.4p. The company plans to cancel these shares, which will reduce the number of shares in issue and leave 284,327,744 ordinary shares outstanding (excluding treasury shares), thereby adjusting the total voting rights used by investors for regulatory disclosure thresholds. The latest transactions, carried out through Peel Hunt LLP, underline Essentra’s ongoing capital management strategy aimed at shrinking its free‑float equity base. The reduction in voting share capital may marginally enhance earnings per share and alter individual shareholders’ percentage holdings, while also clarifying the new denominator investors must use when assessing whether they must notify changes in their stakes under U.K. disclosure rules. The most recent analyst rating on (GB:ESNT) stock is a Buy with a £130.00 price target. To see the full list of analyst forecasts on Essentra stock, see the GB:ESNT Stock Forecast page. **Spark’s Take on ESNT Stock** According to Spark, TipRanks’ AI Analyst, ESNT is a Neutral. The score is weighed down primarily by weak profitability and deteriorating cash flow trends, alongside a very high P/E multiple. Technical indicators also lean bearish with the price below key moving averages and a negative MACD, while the balance sheet and dividend yield provide only modest support. To see Spark’s full report on ESNT stock, click here. **More about Essentra** Essentra plc is a U.K.-listed industrial company whose shares trade on the London Stock Exchange. The group operates through a structure that allows it to conduct share repurchases and manage its capital base, with ordinary shares of 25 pence each forming its primary equity securities for investors. **Average Trading Volume:** 1,076,136 **Technical Sentiment Signal:** Strong Sell **Current Market Cap:** £237.2M For an in-depth examination of ESNT stock, go to TipRanks’ Overview page. ### Related Stocks - [ESNT.UK](https://longbridge.com/en/quote/ESNT.UK.md) - [ESNT.US](https://longbridge.com/en/quote/ESNT.US.md) ## Related News & Research - [Essentra Updates Share Capital and Voting Rights Figure](https://longbridge.com/en/news/284890647.md) - [Essentra CEO Scott Fawcett Buys Additional Shares in the Company](https://longbridge.com/en/news/282815453.md) - [Man Group PLC : Form 8.3 - Senior plc](https://longbridge.com/en/news/296598007.md) - [REG - Franklin Templeton Bodycote PLC - Form 8.3 - Bodycote Plc](https://longbridge.com/en/news/296242803.md) - [REG - Nationwide B.S. Nationwide BS- 34VG - Results RNS - Re-sale of CCDS](https://longbridge.com/en/news/296240068.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**